These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18942197)

  • 21. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma.
    Anderson BD; Schoenfeldt M
    Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226
    [No Abstract]   [Full Text] [Related]  

  • 22. Paving a new road for generating evidence-based care in sepsis*.
    Annane D
    Crit Care Med; 2014 Jul; 42(7):1743-4. PubMed ID: 24933058
    [No Abstract]   [Full Text] [Related]  

  • 23. Activated protein C (Xigris): a drug in trouble.
    Vangerow B; Mignini MA
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261-2. PubMed ID: 17261152
    [No Abstract]   [Full Text] [Related]  

  • 24. Activated protein C: beyond 28 days.
    Manocha S; Walley KR
    Crit Care Med; 2004 Nov; 32(11):2348-9. PubMed ID: 15640656
    [No Abstract]   [Full Text] [Related]  

  • 25. Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.
    Eichacker PQ; Danner RL; Suffredini AF; Cui X; Natanson C
    Crit Care Med; 2005 Oct; 33(10):2426-8. PubMed ID: 16215410
    [No Abstract]   [Full Text] [Related]  

  • 26. Should we treat severe sepsis with activated protein C?
    Mackillop A
    Hosp Med; 2003 May; 64(5):316. PubMed ID: 12789748
    [No Abstract]   [Full Text] [Related]  

  • 27. [Supplementary enzyme treatment of urinary tract infections].
    Naber K
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 9():S327-30. PubMed ID: 19085664
    [No Abstract]   [Full Text] [Related]  

  • 28. The authors reply: academic and industry partnerships.
    Goldstein B; Nadel S; Peters M; Barton R; Machado F; Giroir B
    Pediatr Crit Care Med; 2006 May; 7(3):278-9. PubMed ID: 16682889
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sepsis in the surgical setting: indication for activated C protein].
    Payen DM; Matéo J
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():40-2. PubMed ID: 15359942
    [No Abstract]   [Full Text] [Related]  

  • 30. The Sepsis Saga: Consensus to Xigris.
    Dries DJ
    Air Med J; 2016; 35(4):194-6. PubMed ID: 27393750
    [No Abstract]   [Full Text] [Related]  

  • 31. Combating mortality from severe sepsis.
    Ridley S
    Hosp Med; 2004 Oct; 65(10):580-1. PubMed ID: 15524335
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience with xigris].
    Wyncoll D
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():46-7. PubMed ID: 15359944
    [No Abstract]   [Full Text] [Related]  

  • 33. [Protein C--a new opening in the treatment of sepsis syndrome].
    Petäjä J; Heikinheimo M
    Duodecim; 2002; 118(12):1217-9. PubMed ID: 12239812
    [No Abstract]   [Full Text] [Related]  

  • 34. The search for effective therapy for sepsis: back to the drawing board?
    Angus DC
    JAMA; 2011 Dec; 306(23):2614-5. PubMed ID: 22187284
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein C as a surrogate end-point for clinical trials of sepsis.
    Liu KD; Matthay MA
    Crit Care; 2008; 12(2):139. PubMed ID: 18492215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant activated protein C: the key is clinical assessment of risk of death, not subset analysis.
    Dellinger RP
    Crit Care; 2006 Feb; 10(1):114. PubMed ID: 16542472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forums for expressing concerns.
    Aberegg SK
    Crit Care Med; 2005 Jun; 33(6):1467; author reply 1467-8. PubMed ID: 15942401
    [No Abstract]   [Full Text] [Related]  

  • 38. New mode of intervention in sepsis treatment.
    Foubister V
    Drug Discov Today; 2003 Jul; 8(14):610-2. PubMed ID: 12867140
    [No Abstract]   [Full Text] [Related]  

  • 39. Activated protein C: controversy and hope in the treatment of sepsis.
    Baillie JK
    Curr Opin Investig Drugs; 2007 Nov; 8(11):933-8. PubMed ID: 17979027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.